Press Release: AdhereHealth Adds Healthcare Veteran Brad Fluegel to its Board

Former Walgreens executive joins board of directors at rapidly growing leader in medication adherence solutions

BRENTWOOD, Tenn., April 4, 2019 AdhereHealth™, a leading healthcare technology company focused on medication adherence, has added healthcare veteran Brad Fluegel to its board of directors. Fluegel, formerly chief healthcare commercial market development officer for Walgreens, joins AdhereHealth’s board during a period of expansive growth for the company.

AdhereHealth’s proprietary technology platform, Adhere™, targets an estimated $300 billion in annual unnecessary medical costs caused by gaps in medication adherence.  The Adhere platform uses advanced analytics, home-delivered pharmacy and AdhereHealth’s national footprint of licensed clinicians to navigate social determinants. This unprecedented combination enables AdhereHealth to partner with clients by offering a unique guaranteed fee structure for each consumer’s quality measure conversion.

“AdhereHealth’s approach to improve healthcare outcomes through medication adherence is showing unprecedented impact on quality and reduced healthcare costs,” said Fluegel. “I’m thrilled to join the company’s board and support the company’s mission to improve health through AdhereHealth’s advanced technologies and adherence solutions.”

Prior to Fluegel’s most recent  senior leadership position at Walgreens, Fluegel was chief strategy and external affairs officer at WellPoint (now Anthem) and head of national accounts at Aetna. He currently serves on the boards of Fitbit, Premera Blue Cross and Metropolitan Jewish Health System.

About AdhereHealth™

AdhereHealth™ is a healthcare technology solutions leader supporting health plans, self-insured employers and other risk-bearing entities for medication adherence insights and improved healthcare outcomes. The company’s Adhere™ platform touches nearly 10 million consumers through advanced technologies, at-risk engagement services and home-delivered pharmacy. The integrated set of solutions address an estimated $300 billion of unnecessary annual medical costs attributed to medication

pills in a senior's hands

Overcoming 3 Key Challenges of Medication Adherence for High-Risk Members

For many Americans, taking prescription drugs is a routine – and essential – part of daily life and well-being. In

Compliance Packaging Is Key for Improving High-risk Patient Medication Adherence

Medication adherence is crucial for managing chronic diseases, especially in complex, high-risk patients. Compliance packaging is a key tool for

New CEO Strategies: How Chief Executives Coming Into A Company Can Find Opportunity

By Jason Rose, CEO of AdhereHealth Originally published in Forbes Business Council When an organization gets a new leader from

AdhereHealth’s Digital Pharmacy Launches New Compliance Packaging Solution for Underserved, Higher Risk Patients

AdhereRx “AdherePacks” improve value-based outcomes for higher risk Medicare Advantage and Medicaid patients by simplifying complex drug routines and fostering

AdhereHealth Releases Next-Generation Resolve Offering to Improve Member Experience for CAHPS and HOS Surveys

New Adhere™ Platform capabilities support dramatic CMS Increase of Medicare Advantage CAHPS Member Experience Star Rating Weighting to 32% through

Postdischarge Medication Reconciliation Is the Key to Reducing Hospital Readmissions

Medicare Advantage plans have a clear opportunity to improve quality by delivering more comprehensive, timely medication reconciliation services to recently

AdhereHealth Launches High-Risk Patient COVID-19 Vaccine Accelerator for the Underserved

Innovative solution leverages analytics and outbound tele-pharmacy to ensure equitable access to vaccinations by engaging vulnerable populations and reducing barriers

Medically Necessary: Making the vaccine supply chain work for communities of color

Americans of color are receiving the vaccine at far lower rates than white Americans, even though people of color are

Building a Comprehensive Strategy for Medicare Advantage Star Ratings

Whether you are a health plan leader or financial executive, you’re well aware that achieving and maintaining excellent Medicare Advantage

Medication Adherence Is Key To Addressing the Social Determinants of Health During the COVID-19 Pandemic

More than a year after scientists identified the first cases of COVID-19, infection rates continue to rise in regions across

It’s the Zip Code, Not the Genetic Code—The Need for an Equitable Vaccination Strategy

There is an urgent need to accelerate vaccination distribution for vulnerable Americans by overcoming problems involving social determinants of health.

CMS 2022 Final Rules: Top 6 Things Health Plans Should Know

CMS has finalized a series of policy and technical changes to Medicare Advantage (MA) and the Medicare Prescription Drug Benefit